丹麦Scantox集团于2024年9月9日获得英国基因毒理学领袖Gentronix。 Danish Scantox Group acquires UK's Gentronix, a genetic toxicology leader, on September 9, 2024.

丹麦合同研究机构Scantox集团收购了英国的基因毒理学领导者Gentronix, 增强Scantox在IND前启用研究的能力. Scantox Group, a Danish contract research organization, has acquired UK-based Gentronix, a leader in genetic toxicology, enhancing Scantox's capabilities for pre-IND enabling studies. 该协议于2024年9月9日最终达成,使Gentronix得以扩大其服务,同时保持其品牌。 The deal, finalized on September 9, 2024, allows Gentronix to expand its services while maintaining its brand. 这次采购是一项重大投资,Scantox在整个欧洲雇用了400多名工作人员,重点是管制毒理学和其他专门服务。 The acquisition marks a significant investment, with Scantox employing over 400 staff across Europe, focusing on regulatory toxicology and other specialized services.